Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In laboratory settings, AOD-9604 has been studied for its interactions with beta-3 adrenergic receptors, which play a role in adipocyte metabolism
The FDA clinical studies were focused around correction of moderate to severe facial wrinkles and folds, such as nasolabial folds in adults over the age of 21
The Australian biotech company Metabolic Pharmaceuticals (later Calzada) was founded to bring AOD-9604 to market
They are typically administered intramuscularly (into the muscle)
US$ 25.88
US$ 29.32
US$ 22.18
US$ 24.48
US$ 20.07
US$ 23.46
US$ 24.19
US$ 22.66
US$ 28.46
